BMJ · 1953 · 53 citations · 9 references
MedicineOphthalmologyPediatricsNeonatologyPediatric OphthalmologyPediatric OptometryPediatric Eye DiseasePediatric Retinal DisordersPediatric Vision ScreeningRetinopathy Of PrematurityScreening For Preterm BirthVisual ImpairmentEarly Vision ScreeningGestational Age MeasurementInfant Eye ExaminationNeonatal Visual ScreeningRetinopathy Of Prematurity ScreeningRetinopathy Of Prematurity SurveillanceScreening Criteria DesignScreening Referral Criteria
<h3>Purpose</h3> Provide up-to-date insight in incidence of retinopathy of prematurity (ROP), logistics of screening and treatment in the Netherlands and influence of the new national ROP guideline in which more stringent screening criteria were implemented and the early treatment for ROP criteria (ETROP) were emphasised. <h3>Methods</h3> Multicentre prospective nationwide study including all preterm infants, born in the Netherlands in 2017, and considered eligible for ROP screening. Anonymised data from ophthalmologists and paediatricians were merged. Outcome data were compared with the first national ROP inventory (NEDROP-1, 2009). <h3>Results</h3> In 2017, 1492 infants were live born with gestational age (GA) <32 weeks (2009: 1662); 1287 infants were eligible for screening (2009: 2033). Ophthalmologists screened 1085 infants, versus 1688 in 2009, corrected with factor 1.114 for the difference in number of live births, a 28.4% (479/1688) decrease in screened infants was seen. Among surviving infants with GA <32 week, ROP was found in 305/1492 babies, 20.4% (2009: 324/1662, 19.5%) of which 49/1492 stage ≥3, 3.3% (2009: 30/1662, 1.8%). In all infants, report on presence or absence of plus disease was provided, according to the ETROP criteria. Treatment was performed in 39 infants. Of infants with ROP stage ≥3, 3/49 (6.1%) progressed to retinal detachment (2009: 6/30, 20.0%). <h3>Conclusion</h3> The overall ROP incidence expressed as a percentage, remained stable but the number of infants that developed severe ROP nearly doubled. A near one-third reduction in screened infants shows satisfactory implementation of the new screening criteria. A notable decrease in retinal detachment delineates improved treatment outcome.
9
Treatment of Hypertension by Penta- and Hexa-methonium Salts
F. H. Smirk, K. S. Alstad · BMJ · 1951 · 102 citations · Full text
Treatment of Severe Hypertension with Hexamethonium Bromide
The Treatment of Hypertension with Hexamethonium
E. D. Freis, Frank A. Finnerty, Harold W. Schnaper et al. · Circulation · 1952 · 68 citations · Full text
Methonium Compounds in the Treatment of Hypertension
S. Locket, Patrick G. Swann, W. S. M. Grieve · BMJ · 1951 · 36 citations · Full text
Medicine, Neuroscience, Pharmacology +15
Oral Hexamethonium Bromide in Essential Hypertension
W A Mackey, G. B. Shaw · BMJ · 1951 · 30 citations · Full text